The Naomi Berrie Diabetes Center has launched an initiative to study the relationship between the brain and metabolic disorders such as obesity and diabetes.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.
Dr. Lori Zeltser talks about her research findings, which may lead to a change in approaches to treating childhood obesity.
Targeting an enzyme that raises both sugar and insulin levels in the obese may prevent and treat diabetes.
Columbia has honored Philipp E. Scherer, PhD for helping usher in a new understanding of fat and its role in diabetes and other metabolic diseases.
Stem cells created from the skin of patients with a rare form of diabetes have been used to elucidate an important biochemical pathway for beta-cell failure in diabetes.